Clinical pharmacology of moxalactam in patients with malignant disease
暂无分享,去创建一个
[1] G. Bodey,et al. In vitro studies of 1-oxacephalosporin (LY 127935), a new beta-lactam antibiotic , 1980, Antimicrobial Agents and Chemotherapy.
[2] C. Cobbs,et al. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli , 1979, Antimicrobial Agents and Chemotherapy.
[3] R. Fass. In Vitro Activity of LY127935 , 1979, Antimicrobial Agents and Chemotherapy.
[4] G. White,et al. LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity , 1979, Antimicrobial Agents and Chemotherapy.
[5] H. Neu. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. , 1978, The Journal of infectious diseases.
[6] R. Wise,et al. LY127935, a Novel Oxa-,B-Lactam: an In Vitro Comparison with Other f8-Lactam Antibiotics , 2003 .
[7] M. Levison,et al. Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers. , 1980, Antimicrobial agents and chemotherapy.
[8] R. Davies,et al. Pharmacokinetics and comparative pharmacology of cefoxitin and cephalosporins. , 1979, Reviews of infectious diseases.
[9] W. Ritschel. Handbook of basic pharmacokinetics , 1976 .
[10] J. Ambrus,et al. Causes of death in cancer patients. , 1975, Journal of medicine.